-- Shares Facebook Twitter Reddit Email Major corporations are tapping into the lucrative weight loss drug market, which is anticipated to grow from $6 billion to $100 billion by 2030, per Goldman Sachs . Last month, Costco announced that it was expanding its partnership with Sesame — an online telemedicine platform that connects medical providers nationwide with consumers — to offer eligible members exclusive pricing on prescriptions for GLP-1 weight loss drugs including Ozempic and Wegovy. The big-box retailer's weight loss program followed in the footsteps of rivals Amazon and WeightWatchers , which offer similar services to members.
Same with luxury gyms , like Life Time and Equinox, which debuted new clinics to accommodate their growing number of members who are on such medications. Now, Nestlé is joining the mix with a new frozen food brand for individuals taking GLP-1 drugs. Called Vital Pursuit, the brand will include 12 portion-controlled meals, high in fiber and protein, “intended to be a companion for GLP-1 weight loss medication users and consumers focused on weight management,” the company announced Tuesday.
The meals will be available in select stores later this year and may come with a suggested retail price of $4.99 or less, CNN reported . “We know that every consumer on a health journey has individualized needs and considerations, and having options to support those needs will continue to play an important role,” Tom Moe, president of Nestle USA.
